Drug
Vit 2763 QD
Vit 2763 QD: highest development phase Phase 2, developed by Vifor Pharma. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Vifor Pharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| VIT-2763 60 mg QD NCT04938635 | Phase 2 | Beta-Thalassemia |
Latest
No recent events.
Follow Vit 2763 QD on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.